Related references
Note: Only part of the references are listed.Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity
Catherine Riou et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
Saurabh Dahiya et al.
BLOOD ADVANCES (2022)
Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients
Bernice Ling Zhi Oh et al.
BLOOD (2022)
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy
Djordje Atanackovic et al.
BLOOD (2022)
Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine
Chunfeng Li et al.
NATURE IMMUNOLOGY (2022)
The changing epidemiology of SARS-CoV-2
Katia Koelle et al.
SCIENCE (2022)
The immunology and immunopathology of COVID-19
Miriam Merad et al.
SCIENCE (2022)
HOW THE CORONAVIRUS INFECTS OUR CELLS
Megan Scudellari
NATURE (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
Abi Vijenthira et al.
BLOOD (2020)